Clinical trial
Efficacy and Safety of Combination Therapy of Moderate-intensity Statin and Ezetimibe Compared to High-intensity Statin: Study Protocol for a Randomized Controlled Trial
NCT04080310 is registered in ClinicalTrials.gov with Seoul National University Bundang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Combination Therapy of Moderate-intensity Statin and Ezetimibe Compared to High-intensity Statin: Study Protocol for a Randomized Controlled Trial
- Lead sponsor
- Seoul National University Bundang Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 15, 2018
- Completion date
- September 17, 2019
- Enrollment
- 270 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.